Newsfeeds Archive - Spark Newswire

4 minute read

Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

May 20, 1:28 PM

Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday’s session after the company priced a $1.7 million…

AKAN

2 minute read

Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday

By Avi Kapoor

May 20, 11:37 AM

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Monday. Shares of Overseas Shipholding…

AZZ

3 minute read

Analyst Ratings

Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts

By Benzinga Insights

May 8, 9:00 AM

Sutro Biopharma (NASDAQ:STRO) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from…

STRO

2 minute read

News

What’s Going On With Sutro Biopharma (STRO) Stock?

By Henry Khederian

April 2, 12:46 PM

Sutro Biopharma shares are trading lower by 4.3% during Tuesday's session. The company announced the pricing of an underwritten offering.

STRO

4 minute read

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Avi Kapoor

March 28, 2:08 PM

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

ABTS

2 minute read

REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday

By Avi Kapoor

March 28, 11:00 AM

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat quarterly earnings.

ALT

3 minute read

Analyst Ratings

Navigating 4 Analyst Ratings For Sutro Biopharma

By Benzinga Insights

March 27, 8:01 AM

Ratings for Sutro Biopharma (NASDAQ:STRO) were provided by 4 analysts in the past three months, showcasing a mix…

STRO

3 minute read

Sutro Biopharma Highlights Potential Multi-Cancer Opportunity For Luvelta, A FolRα-targeting ADC

By Benzinga Newsdesk

January 4, 5:16 PM

Ovarian cancer data supports registration-enabling trial of luvelta for women with platinum-resistant ovarian cancer Potential benefit to 8 out of 10 platinum-resistant ovarian cancer patients, including addressing

STRO

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

November 30, 9:06 AM

Gainers Immunogen (NASDAQ:IMGN) shares moved upwards by 83.0% to $29.39 during Thursday’s pre-market session. The company’s market cap…

ADTX

2 minute read

Vaxcyte Exercises Option And Enters Into Manufacturing Rights Agreement With Sutro Biopharma To Obtain Control Over Manufacturing And Development Of Cell-Free Extract For Its Vaccine Candidates

By Benzinga Newsdesk

November 27, 5:01 PM

-- Vaxcyte Obtains Exclusive Rights to Independently Develop and Manufacture Cell-Free Extract, a Key Component of the Company's Pneumococcal Conjugate Vaccine (PCV) Franchise -- -- Manufacturing Rights Agreement

PCVX